| Revenue | 2,932.72a | 2,634.33a | 2,410.93a | 1,729.91a | 1,328.12a |
| Cost of sales | -1,451.35a | -1,362.64a | -1,268.05a | -901.78a | -704.55a |
| Gross profit | 1,481.37a | 1,271.7a | 1,142.88a | 828.13a | 623.57a |
| Other income | 7.39a | 0.07a | 0.04a | 4.07a | -0.62a |
| Operating expenses | — | — | — | — | — |
| Selling, general and administrative | -316.81a | -308.73a | -276.62a | -189.55a | -156.8a |
| Research and development | -369.82a | -309.3a | -233.87a | -151.2a | -139a |
| Total operating expenses | -686.63a | -618.02a | -510.49a | -340.74a | -295.8a |
| Result from operations | 802.14a | 653.74a | 632.44a | 491.46a | 327.14a |
| Finance income | 21.66a | 14.83a | 2.25a | 0.02a | 0.14a |
| Finance expense | -10.58a | -13.6a | -4.1a | -2.01a | -2.3a |
| Foreign currency exchange gain (loss) | 45.05a | -21.38a | 25.01a | 33.47a | -22.86a |
| Net finance income (costs) | 56.12a | -20.15a | 23.16a | 31.48a | -25.03a |
| Share in income of investments in associates | 9.64a | 17.54a | 64.77a | 74.38a | 31.95a |
| Reversal of impairment of investments in associates, net | | 215.39a | -215.39a | | |
| Result before income taxes | 867.9a | 866.52a | 504.98a | 597.32a | 334.07a |
| Income taxes | -182.17a | -114.45a | -115.86a | -102.62a | -48.67a |
| Net earnings from operations, attributable to common shareholders | 685.73a | 752.07a | 389.11a | 494.71a | 285.4a |